For people with overweight or obesity and pre-existing cardiovascular disease (CVD), taking semaglutide for three years resulted in 20% fewer heart attacks, strokes, and deaths, compared to those taking a placebo, according to the new study
Gastrointestinal satiety signals in humans - physiologic roles for GLP-1 and PYY
What is tirzepatide and how does it function
Curiously, it was recently reported that this pro-inflammatory cytokine, IL-6, similarly, but independently from GLP-1, slows gastric emptying (228)
How a Mounjaro restart is assessed after a longer break NICEs guidance on prescribing, reviewing and stopping tirzepatide sets out the factors a prescriber should weigh when someone wants to restart, rather than a single fixed schedule: Why treatment was stopped Whether pancreatitis was suspected or confirmed Whether other adverse effects occurred, and how significant they were Previous weight-loss response to treatment How long treatment was taken for, and the highest dose reached Engagement with diet and lifestyle measures during previous treatment Whether a slower dose titration is appropriate this time This reflects the official UK missed-dose instruction (take within four days, otherwise skip, leave at least three days between doses) plus the individual factors NICE sets out for a longer break